We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
-$76M
Cap. Flow
-$97.6M
Cap. Flow %
-49.58%
Top 10 Hldgs %
44.5%
Holding
160
New
26
Increased
14
Reduced
15
Closed
66

Top Buys

Rank Stock Value
1
ATXS
Astria Therapeutics
ATXS
+$9.39M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$4.07M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.73M
4
OTLK icon
Outlook Therapeutics
OTLK
+$3.62M
5
REPL icon
Replimune Group
REPL
+$3.32M

Top Sells

Rank Stock Value
1
CCXI
ChemoCentryx, Inc.
CCXI
+$8.27M
2
INSM icon
Insmed
INSM
+$5.77M
3
MBTC
Nocturne Acquisition Corporation Ordinary Shares
MBTC
+$5.17M
4
BCAB icon
BioAtla
BCAB
+$4.26M
5
ILMN icon
Illumina
ILMN
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 88.67%
2 Financials 5.8%
3 Communication Services 0.42%
4 Industrials 0.36%
5 Materials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEV.WS
76
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$25.3K 0.01%
652,173
– –
PEPLW
77
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$24.1K 0.01%
367,500
– –
BNCWW
78
CEA Industries Inc Warrant
BNCWW
$22.5K 0.01%
250,000
– –
MOBXW icon
79
Mobix Labs Warrants
MOBXW
$752K
$21.7K 0.01%
150,000
– –
NXLIW
80
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$21K 0.01%
105,000
– –
TLRY icon
81
CALL
Tilray
TLRY
$622M
$20.4K 0.01%
+760
New +$26.6K
BRSHW
82
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$19.5K 0.01%
360,579
+240,386
+200% +$64.8K
LUCYW icon
83
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$123K
$18.3K 0.01%
150,000
– –
HCDIW
84
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$17.4K 0.01%
600,000
– –
VSEEW
85
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$14.8K 0.01%
+150,000
New +$15.8K
OSAAW
86
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$11.8K 0.01%
+150,000
New +$20.7K
SLNAW
87
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$8.12K ﹤0.01%
+101,439
New +$18.5K
EUCRW
88
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$7.41K ﹤0.01%
133,333
– –
SRZNW icon
89
Surrozen Inc Warrant
SRZNW
$8.86K
$7.02K ﹤0.01%
82,233
– –
OHAAW
90
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$3.23K ﹤0.01%
50,000
– –
RACYW
91
DELISTED
Relativity Acquisition Corp. Warrant
RACYW
$3.01K ﹤0.01%
+100,000
New +$2.91K
MITAW
92
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$2.03K ﹤0.01%
28,333
– –
TCBPW
93
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$1.68K ﹤0.01%
18,823
-922,353
-98% -$127K
PSQH.WS icon
94
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$1.43K ﹤0.01%
16,666
– –
ACET icon
95
Adicet Bio
ACET
$74.7M
– –
-9,375
Closed -$2.13M
AFMD
96
DELISTED
Affimed
AFMD
– –
-90,000
Closed -$1.85M
ALKS icon
97
Alkermes
ALKS
$8.25B
– –
-70,000
Closed -$1.56M
AMLX icon
98
PUT
Amylyx Pharmaceuticals
AMLX
$2.54B
– –
-9,000
Closed -$253K
ANGO icon
99
AngioDynamics
ANGO
$649M
– –
-195,000
Closed -$3.99M
ATEC icon
100
Alphatec Holdings
ATEC
$1.44B
– –
-342,000
Closed -$2.99M
2 3
4
5 6

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Altium Capital Management held 160 positions worth $197M, down 28% from $273M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Altium Capital Management withdrew a net $97.6M in Q4 2022, closing 66 positions and reducing 15 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $8.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 79% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Altium Capital Management opened a new position in Tandem Diabetes Care worth $4.05M.

  • Altium Capital Management's largest Q4 2022 buy was Tandem Diabetes Care: 90,000 shares worth $4.05M.
  • Altium Capital Management added most to Astria Therapeutics in Q4 2022, an estimated $9.39M increase.
  • Altium Capital Management's biggest Q4 2022 reduction was Chinook Therapeutics, Inc. Common Stock, cutting an estimated $3.1M.
  • Altium Capital Management fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $8.27M.
  • Altium Capital Management's ten largest holdings make up 45% of its $197M portfolio in Q4 2022.
  • Altium Capital Management opened 26 new positions and closed 66 in Q4 2022.
  • Altium Capital Management's portfolio value fell 28% quarter-over-quarter to $197M.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.